The Company has received approval to list its common shares on the Nasdaq Capital Market under the symbol “ACOG” and is ...

Clene met with the U.S. Food and Drug Administration (FDA) on November 1, 2024, in a Type C meeting to discuss the potential for an accelerated approval pathway in ALS ... and the Company’s existing ...

“We also announced that the FDA has approved our IDE application allowing us to move ... InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information ...

Change of the Company’s corporate name to Grace Therapeutics, Inc. The Company’s common stock commenced trading under the trading symbol “GRCE” on Nasdaq ... (A-T), for which there are currently no ...

The FDA has granted Jan123 Orphan ... and its Nasdaq ticker symbol was updated to ALTS. On August 26, 2024, the Company appointed Peter Tassiopoulos as CEO. In October, the Board approved the ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

Discover the cutting-edge Apple Intelligence features introduced in iOS 18.1 that enhance user experience and functionality.

TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral” or the "Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) (“KalVista”), today announced the closing of a synthetic royalty financing agreement with DRI Healthcare Trust (“DRI”) for up to $179 million, comprised ...

In August, the FDA approved Ascendis Pharma’s Yorvipath ... it snagged the fitting stock symbol “GPCR”). Lead Structure drug candidate GSBR-1290 is currently in mid-stage clinical ...

FDA's Human Foods Program released its 2025 Priority Deliverables today, which details the primary focuses for its first year under the reorganization. Highlights include a goal to issue guidance on ...

People with Type 1 diabetes (such as myself) can connect their Dexcom blood-glucose sensor—an FDA-approved medical device ... just a novelty or status symbol. It’s a genuine boon to healthcare.